drugset / Trial / NCT00828308
Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer
Phase 2
Completed
16 enrolled
Brown University
Rhode Island Hospital · collabThe Miriam Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
Ixabepilone, 16 mg/m2 or 20mg/m2, weekly x 3, in 4 week cycles, x 4 cycles. Prostatectomy 2-8 weeks after completion(standard of care and not a part of study)
Timeline
- Start
- 2009-02
- Primary completion
- 2011-03
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixabepilone | Small molecule | 16 mg/m2 | — |
| Subject | Ixabepilone | Small molecule | 20 mg/m2 | — |